What is Egrifta?
Egrifta (tesamorelin) is a prescription treatment designed to reduce excess abdominal fat in adults living with HIV who develop lipodystrophy.
Lipodystrophy is a condition where fat is distributed unevenly in the body, often leading to a buildup of deep abdominal fat known as visceral fat.
This fat surrounds internal organs and is more difficult to reduce through diet and exercise alone.
Egrifta is administered as a once-daily injection under the skin. It works by increasing the release of growth hormone in the body, which helps break down this deep belly fat over time.
Many patients choose to buy Egrifta online or from Canada to help manage treatment expenses, as pricing can vary depending on the source.
Indications and Benefits of Egrifta
Egrifta is prescribed for adults living with HIV who develop excess fat in the abdominal area due to lipodystrophy.
This condition can change physical appearance and may also place added strain on internal organs. Egrifta focuses on reducing visceral fat, which is the deeper type of fat stored around the organs and linked to greater health concerns.
Egrifta is not intended for general weight loss.
What Are the Benefits of Egrifta?
- Reduces stubborn abdominal fat that is difficult to improve with diet and exercise alone
- Targets visceral fat that surrounds organs and is associated with higher health risks
- Helps improve body shape in individuals with HIV-related lipodystrophy
- May ease pressure on internal organs caused by fat accumulation
- Stimulates natural growth hormone release to support fat breakdown
- Follows a simple once-daily injection routine
- Delivers focused treatment through proper abdominal injection
- Allows dose adjustments based on individual response and goals
- Offers a treatment option when lifestyle changes are not enough
- Can be evaluated alongside alternative treatments when considering options
Egrifta Drug Information
| Fact Category | Fact Details |
| Generic Name | The generic name of Egrifta is tesamorelin. |
| Egrifta Class | Egrifta belongs to the class of growth hormone-releasing factor analogs. |
| Primary Use | It is primarily used to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. |
| Additional Benefit | It helps target visceral fat and may support improved body shape and metabolic health. |
| Available Form | Egrifta is available as an injectable powder that is mixed into a solution before use. |
| Method of Administration | It is given as a subcutaneous injection into the abdominal area. |
| Frequency | It is typically administered once daily. |
| Storage Instructions | It should be stored in the refrigerator, protected from light, and should not be frozen. After mixing, it should be used as directed and not stored for later use. |
| Pregnancy and Breastfeeding | It is not recommended during pregnancy, and breastfeeding should be discussed with a doctor due to possible risks. |
| Drug Interactions | It may interact with glucocorticoids, insulin, oral glucose-lowering drugs, and other treatments that affect hormone levels. |
| Manufacturer | Egrifta is manufactured by Theratechnologies. |
How It Works
Egrifta helps your body release more of its natural growth hormone, which is a substance your body already makes to control how fat is used and stored.
It works by acting on a small part of the brain called the pituitary gland, which is like a control center that tells your body when to release certain hormones.
When growth hormone levels increase, your body also produces another helper called insulin-like growth factor 1.
This supports the process of breaking down stored fat. Egrifta mainly targets visceral fat, which is the deep fat that builds up around your organs in the belly and is harder to lose with diet and exercise.
By helping your body use and break down this fat more effectively, Egrifta can reduce belly fat linked to lipodystrophy, without directly causing overall weight loss.
Dosage
Egrifta dosing depends on the formulation prescribed, either Egrifta WR or Egrifta SV. Both options are given as a once-daily injection under the skin in the abdominal area.
The preparation steps and exact dose can vary between these two formulations, so they should not be used interchangeably. Your doctor will provide clear instructions on how to mix the solution and use the correct injection technique.
What Dosage Strengths Does Egrifta Come In?
- Egrifta WR 11.6 mg per vial
- Egrifta SV 2 mg per vial
Dosage Chart
| Population | Formulation | Dose | How to Use | Notes |
| Adults with HIV-associated lipodystrophy | Egrifta SV | 1.4 mg once daily | Inject 0.35 mL under the skin of the abdomen | Use immediately after mixing and rotate injection sites |
| Adults with HIV-associated lipodystrophy | Egrifta WR | As prescribed | Inject under the skin of the abdomen | Follow specific preparation instructions and do not substitute with SV |
| General adult use | Both | Once daily | Subcutaneous injection in the abdomen | Always follow the doctor’s instructions |
| Missed dose | Both | Skip the missed dose | Take the next dose at the regular time | Do not take two doses at once |
| Special cases | Both | Individualized dosing | Based on patient response | May require monitoring and adjustments |
Usage Guide
Egrifta is given as a once-daily injection under the skin of the abdomen to help reduce excess belly fat associated with HIV-related lipodystrophy.
Using Egrifta correctly is important for achieving the best results and lowering the risk of side effects. A doctor will explain how to prepare and administer the injection based on whether you are using Egrifta WR or Egrifta SV.
These two formulations have different preparation and dosing steps, so they should not be used interchangeably without medical advice.
Staying consistent with your daily schedule, using the correct injection technique, and choosing proper injection areas can help improve results over time.
How do you take Egrifta?
- Follow your prescribed dosing schedule exactly as directed
- Inject under the skin of the abdomen using proper technique
- Prepare the solution correctly before each injection
- Rotate injection spots on the abdomen to help prevent irritation
- Avoid areas with scars, bruising, or near the belly button
- Use the injection at the same time each day for consistency
- Never share needles or syringes to avoid infection risk
- Dispose of used needles safely after each use
- Contact your doctor if you notice unusual reactions or have concerns
Side Effects
Egrifta can cause side effects that range from mild discomfort to more serious reactions, depending on how your body responds to treatment.
This injectable treatment increases growth hormone levels, which can influence different parts of the body. Many side effects are mild and temporary, but some may need medical attention.
Common Side Effects
- Discomfort or aching in the arms and legs
- Muscle soreness that may affect daily movement
- Reactions at the injection site, such as redness, itching, or slight swelling
- Minor bruising or irritation where the injection was given
- Mild swelling in the hands, feet, or joints
Serious Side Effects
- Possible increased risk of cancer or recurrence of previous cancer
- Elevated insulin-like growth factor 1 levels may require regular blood tests
- Higher blood sugar levels, which may lead to diabetes or worsen existing diabetes
- Fluid buildup that can cause swelling, joint pain, or numbness in the hands and wrists
- Severe allergic reactions, including rash, hives, swelling of the face or throat, or trouble breathing
- Intense injection site reactions, such as significant pain, bleeding, or swelling
- Greater risk of complications in people with serious illnesses, especially after surgery or breathing difficulties
Missed Dose
If you forget to take a dose of Egrifta, simply skip it and continue with your next dose at the regular time.
Do not try to make up for it by taking an extra dose. Staying on a consistent daily schedule helps maintain steady results, so it is best to take it at the same time each day whenever possible.
Overdose
Taking more Egrifta than prescribed can increase the chance of unwanted effects such as swelling, joint discomfort, or changes in blood sugar levels. If an overdose is suspected, seek medical attention immediately. Monitoring may be required to manage symptoms and avoid further complications.
Storage Information
Egrifta should be kept at room temperature, ideally between 20°C and 25°C, and stored in its original packaging to protect it from light.
Avoid freezing the product. Once the solution is prepared, use it within the recommended time and discard any remaining portion as directed.
Keep all supplies in a clean, dry area and out of reach of children.
Warnings
Before starting Egrifta, it is important to understand the safety precautions. This treatment affects hormone levels, which are chemical messengers in the body that control processes like growth and fat use. Because of this, it can influence different organs and body systems.
- Egrifta may not be suitable for everyone, especially people with certain medical conditions.
- Do not use Egrifta if you have a history of problems with the pituitary gland, which is a small part of the brain that controls hormone release
- Avoid using it if you have active cancer or if past cancer has not been fully treated, since increased growth hormone may encourage cell growth
- Do not use if you are allergic to tesamorelin or any of its ingredients
- Do not use during pregnancy, as it may harm the developing baby
- Use with caution if you have had cancer before, as there may be a risk of it returning
- Monitor blood sugar levels closely, especially if you have diabetes, since treatment may cause them to rise
- Watch for vision changes, as high blood sugar can affect the eyes over time
- Inform your doctor before any planned surgery, including procedures involving the heart or stomach
- Use carefully if you have breathing problems, as certain conditions may increase risks during treatment
- Avoid breastfeeding, as it is not known if the drug passes into breast milk, and there is also a risk of HIV transmission
- Always review any other drugs, supplements, or vitamins you are taking to avoid unwanted interactions
Boxed Warning and Precautions for Egrifta
| Egrifta includes important safety warnings related to its effects on hormones. Because it increases growth hormone activity, there may be a risk of new cancer or the return of previous cancer, so proper screening is needed before starting treatment. Higher levels of growth-related hormones can also affect blood sugar, fluid balance, and overall body function. In some cases, serious reactions such as severe allergies or complications in people who are critically ill may occur, which is why close medical supervision is important during treatment. |
Contraindications
Egrifta should not be used in certain situations because it may not be safe. Contraindications mean conditions where a treatment must be avoided.
- Do not use Egrifta if you have a history of problems with the pituitary gland, which is a small part of the brain that controls hormone release. This includes tumors, surgery, or injury that may affect how hormones are produced.
- Avoid use if you have active cancer or cancer that has not been fully treated, as increased hormone activity may cause cancer cells to grow or return.
- Do not use if you have an allergy to tesamorelin or any of its ingredients, since this may lead to serious allergic reactions.
- Do not use during pregnancy, as it may harm the unborn baby.
Interactions
Egrifta may interact with other drugs that affect hormones or how the body processes substances. These interactions can change how treatments work or increase the risk of side effects.
- Cholesterol-lowering drugs such as simvastatin, atorvastatin, and lovastatin
- Corticosteroids such as hydrocortisone, dexamethasone, and methylprednisolone, which are used to reduce inflammation
- Sex hormones such as estradiol, testosterone, and progesterone
- Seizure treatments such as phenytoin, carbamazepine, and valproic acid
- Cyclosporine, which is used to suppress the immune system
- Glucocorticoids such as prednisone and prednisolone, which are types of steroid treatments
- Cortisone acetate and other related steroid-based treatments
Alternatives
Egrifta alternatives can be explored depending on your condition, treatment goals, and overall health.
One possible option is Myalept (metreleptin). It works in a different way by replacing leptin, which is a natural hormone that helps control how the body stores and uses fat.
This option is usually used for specific fat disorders and may be considered in certain cases of abnormal fat distribution.
Other options may include therapies that affect growth hormone levels or treatments that support metabolism, which is how the body converts food into energy. These approaches may be considered based on the underlying condition.
The best choice will depend on your medical history, how your body responds to treatment, and your long-term health goals.
Cost & Coupons
Buy Egrifta Online From Canada
Pharma Giant offers Egrifta at a more affordable price by partnering with licensed Canadian pharmacies. This helps ensure you receive high-quality treatment while paying significantly less compared to U.S. prices.
- Lower prices compared to typical U.S. costs
- Supplied through licensed Canadian pharmacy partners
- Reliable delivery across the United States
- Simple ordering process with transparent pricing
- Extra savings when ordering up to a 3-month supply
- Prescriptions reviewed by U.S.-licensed doctors and Canadian pharmacists
- Careful packaging for temperature-sensitive products
Egrifta Discounts and Coupons from Pharma Giant
Use code PGSAVE10 at checkout to get 10% off your first Egrifta order.
How to Order?
| Step 1: Search for Egrifta on the website, select the correct strength and quantity, then add it to your cart.
Step 2: Enter your contact details, shipping information, and payment details. Create an account if you are new or log in if you already have one. Step 3: Upload your prescription through the website, or send it by email or fax if required. Non-prescription items do not need a prescription. Apply code PGSAVE10 to receive your 10% discount on your first purchase. |
Pharma Giant’s Guarantee
Pharma Giant focuses on safety, quality, and savings. All products are sourced from licensed Canadian pharmacies to provide trusted treatment at lower prices than those found in the United States.
You can order up to a 3-month supply to maximize savings. Every prescription is reviewed and approved before shipping, ensuring that each order is safe, authentic, and suitable for your needs.
With Pharma Giant, you get dependable service, secure ordering, and meaningful savings in one place.
Frequently Asked Questions
Buying Egrifta from Canada
FDA-Prescription, Off-Label Information, and Limitations
Dosage & Administration
Adverse Reactions
Food & Drug Interactions
Storage & Travel
Drug Comparison
Disclaimer
Pharma Giant provides medical information to help you better understand medications and medical conditions.This content is for informational use only and does not replace advice from a licensed medical practitioner. Consult your doctor or pharmacist before starting or changing any medication. All our partners follow strict safety standards set by their country’s health authorities to make sure you receive safe and high-quality medications.
| Have a prescription?
Order Egrifta online today and enjoy a host of benefits, including: |
 |
